Suppr超能文献

催乳素受体表达增加与喉恶性肿瘤相关。

Increased expression of the prolactin receptor is associated with malignant laryngeal tumors.

作者信息

González-Lucano Luis R, Muñoz-Valle José F, Ascencio-Cedillo Rafael, Domínguez-Rosales José A, López-Rincón Gonzalo, Del Toro-Arreola Susana, Bueno-Topete Miriam, Daneri-Navarro Adrián, Estrada-Chávez Ciro, Pereira-Suárez Ana L

机构信息

Departments of Physiology, and.

出版信息

Exp Ther Med. 2012 Apr;3(4):603-607. doi: 10.3892/etm.2012.464. Epub 2012 Jan 30.

Abstract

The altered expression of the prolactin receptor (PRLR) has been associated with the development of various types of cancer, particularly breast, prostate and endometrial cancer. However, in laryngeal tumors, the expression of PRLR has not yet been documented. The aim of this study was to determine the expression and localization of PRLR in laryngeal cancer (LC) in comparison with recurrent respiratory papillomatosis (RRP). PRLR expression was analyzed in 48 paraffin-embedded tissues (18 RRP and 30 laryngeal cancer tissues) by immunoperoxidase staining. Furthermore, PRLR expression was evaluated in ten samples from each group by Western blot analysis and quantitative real-time PCR. PRLR was observed in all laryngeal tumors at different intensities. PRLR overexpression was significantly associated (P<0.005) with LC. The staining pattern was homogeneous, mainly cytoplasmic, and confined to the tumor area. We found increased expression of different isoforms in LC in comparison with RRP. Our results suggest a possible role of PRL/PRLR in the development of LC. PRLR may be useful as a target for further investigations in laryngeal tissues.

摘要

催乳素受体(PRLR)表达的改变与多种类型癌症的发生发展有关,尤其是乳腺癌、前列腺癌和子宫内膜癌。然而,在喉肿瘤中,PRLR的表达尚未见报道。本研究的目的是确定PRLR在喉癌(LC)中的表达和定位,并与复发性呼吸道乳头状瘤病(RRP)进行比较。通过免疫过氧化物酶染色分析了48例石蜡包埋组织(18例RRP和30例喉癌组织)中PRLR的表达。此外,通过蛋白质免疫印迹分析和定量实时聚合酶链反应对每组的10个样本进行PRLR表达评估。在所有喉肿瘤中均观察到不同强度的PRLR。PRLR过表达与LC显著相关(P<0.005)。染色模式均匀,主要位于细胞质,且局限于肿瘤区域。我们发现与RRP相比,LC中不同异构体的表达增加。我们的结果提示PRL/PRLR在LC发生发展中可能发挥作用。PRLR可能作为喉组织进一步研究的靶点。

相似文献

1
Increased expression of the prolactin receptor is associated with malignant laryngeal tumors.
Exp Ther Med. 2012 Apr;3(4):603-607. doi: 10.3892/etm.2012.464. Epub 2012 Jan 30.
3
Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice.
Gastroenterology. 2020 Apr;158(5):1433-1449.e27. doi: 10.1053/j.gastro.2019.11.279. Epub 2019 Nov 29.
5
Prolactin as a local growth promoter in patients with locally advanced tongue cancer: GCRI experience.
Head Neck. 2000 May;22(3):257-64. doi: 10.1002/(sici)1097-0347(200005)22:3<257::aid-hed8>3.0.co;2-k.
6
Prolactin Receptor Expression is an Independent Favorable Prognostic Marker in Human Breast Cancer.
Appl Immunohistochem Mol Morphol. 2016 Apr;24(4):238-45. doi: 10.1097/PAI.0000000000000178.
10
Histone trimethylation of the p53 gene by expression of a constitutively active prolactin receptor in prostate cancer cells.
Chin J Physiol. 2013 Oct 31;56(5):282-90. doi: 10.4077/CJP.2013.BAB139. Epub 2013 Aug 31.

引用本文的文献

1
STAT3 activation is required for the antiapoptotic effects of prolactin in cervical cancer cells.
Cancer Cell Int. 2015 Sep 4;15:83. doi: 10.1186/s12935-015-0234-9. eCollection 2015.
2
Prolactin and prolactin receptor expression in cervical intraepithelial neoplasia and cancer.
Pathol Oncol Res. 2015 Apr;21(2):241-6. doi: 10.1007/s12253-014-9814-6. Epub 2014 Jul 3.
3
Prolactin and cancer: Has the orphan finally found a home?
Indian J Endocrinol Metab. 2012 Dec;16(Suppl 2):S195-8. doi: 10.4103/2230-8210.104038.

本文引用的文献

1
Prolactin receptor is a negative prognostic factor in patients with squamous cell carcinoma of the head and neck.
Br J Cancer. 2011 May 10;104(10):1641-8. doi: 10.1038/bjc.2011.131. Epub 2011 Apr 19.
3
Clinicopathological significance of prolactin receptor expression in colorectal carcinoma and corresponding metastases.
Mod Pathol. 2010 Jul;23(7):961-71. doi: 10.1038/modpathol.2010.83. Epub 2010 May 7.
4
Impact of prolactin receptor isoforms on reproduction.
Trends Endocrinol Metab. 2010 Jun;21(6):362-8. doi: 10.1016/j.tem.2010.01.008. Epub 2010 Feb 9.
5
Serum prognostic markers in head and neck cancer.
Clin Cancer Res. 2010 Feb 1;16(3):1008-15. doi: 10.1158/1078-0432.CCR-09-2014. Epub 2010 Jan 26.
6
Biological significance of prolactin in gynecologic cancers.
Cancer Res. 2009 Jun 15;69(12):5226-33. doi: 10.1158/0008-5472.CAN-08-4652. Epub 2009 Jun 2.
9
Oncogene-mediated inhibition of glycogen synthase kinase 3 beta impairs degradation of prolactin receptor.
Cancer Res. 2008 Mar 1;68(5):1354-61. doi: 10.1158/0008-5472.CAN-07-6094.
10
Altered expression of prolactin receptor-associated signaling proteins in human breast carcinoma.
Mod Pathol. 2008 May;21(5):565-71. doi: 10.1038/modpathol.2008.7. Epub 2008 Feb 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验